Showing results (1-10 of 67) with videos related to
Sort By:
Pageof 7
Nursing Standard (Royal College of Nursing (Great Britain) : 1987)|March 3, 2009
Providing patients with information on pharmacogenetic testingNigel Fleeman, Rumona DicksonPharmacoeconomics|August 21, 2014
Pertuzumab in combination with trastuzumab and docetaxel for the treatment of HER2-positive metastatic or locally recurrent unresectable breast cancerNigel Fleeman, Adrian Bagust, Sophie Beale, et al.Pharmacoeconomics|May 15, 2010
Cetuximab for recurrent and/or metastatic squamous cell carcinoma of the head and neck: a NICE single technology appraisalAdrian Bagust, Janette Greenhalgh, Angela Boland, et al.Health Technology Assessment (Winchester, England)|June 27, 2014
Allopurinol for the treatment of chronic kidney disease: a systematic reviewNigel Fleeman, Gerlinde Pilkington, Yenal Dundar, et al.Pharmacoeconomics|April 24, 2015
Dabrafenib for Treating Unresectable, Advanced or Metastatic BRAF V600 Mutation-Positive Melanoma: An Evidence Review Group PerspectiveNigel Fleeman, Adrian Bagust, Sophie Beale, et al.Personalized Medicine|May 20, 2018
Are health technology assessments of pharmacogenetic tests feasible? A case study of CYP2D6 testing in the treatment of breast cancer with tamoxifenNigel Fleeman, Katherine Payne, William G Newman, et al.Health Technology Assessment (Winchester, England)|April 26, 2016
The clinical effectiveness and cost-effectiveness of heated humidified high-flow nasal cannula compared with usual care for preterm infants: systematic review and economic evaluationNigel Fleeman, James Mahon, Vickie Bates, et al.Journal of Allied Health|December 22, 2010
Healthcare students' e-literacy skillsCary A Brown, Rumona DicksonPapua and New Guinea Medical Journal|November 27, 2014
Perceptions and use of maternal health services by women in rural coastal Madang ProvinceSue King, Megan Passey, Rumona DicksonPageof 7